Whether you’re an independent single physician practice or a private equity, multi-state multi-specialty physician group – we have helped all sizes navigate the challenges of growth. From formulating strategies around acquisition and de novo growth to building complex data dashboards – our company has helped practices in GI, Dermatology, Orthopaedics & more.

We represent numerous ASC’s across the country in their negotiations with health plans.  We understand the complexity of ASC’s and their importance in the marketplaces they serve.  As a preferred negotiating provider of ASC’s, our team is equiped with the knowledge and reputation of negotiating better contracts for both the facility and professional providers that staff them.  Reach out today to learn more about our ASC team and the various clients we have helped!

We have a team of experts focused on the pharmaceutical industry to help you navigate the changing landscape of complex infusion drug delivery. We have helped hospitals, 340B programs, free standing infusion centers and large national cancer treatment groups negotiate better drug reimbursement. We are focused on helping clients achieve margin growth for a sustainable future in treating patients with complex illnesses.

Private equity in the last decade is rapidly growing within the healthcare space.  Much of this growth has risen due to the fragmentation of providers and their inability to develop scale and growth or sustain profitable growth.  We work with PE firms from both a diligence perspective on acquisitions and de novo growth to hands on assistance of their portfolio companies.  Our firm has created significant return on invested capital for many PE groups by helping them navigate the entire payer portfolio process.  If your firm is considering buying, expanding or looking to develop stronger margins – our team is here to help!